The Tisch Cancer Institute at Mount Sinai is a vital component of the Icahn School of Medicine at Mount Sinai and part of the Mount Sinai Health System. An NCI-Designated Cancer Center since 2015, it has distinct research programs in Cancer Immunology, Cancer Mechanisms, Cancer Prevention and Control, and Cancer Clinical Investigation (including a robust infrastructure for clinical trials and an Early Phase Trials Unit). It supports current shared resources in Flow Cytometry, Mouse Genetics, Microscopy, Biostatistics, and a Human Immune Monitoring Center.
The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of the Top 20 Best Hospitals in the country and the Icahn... School of Medicine as one of the Top 20 Best Medical Schools in the country.
Mount Sinai embraces the principles of diversity and inclusion as key drivers for excellence and innovation for unrivaled healthcare service delivery, medical and health education, and research.